Rigel Pharmaceuticals
RIGL
#6719
Rank
โ‚ฌ0.45 B
Marketcap
25,98ย โ‚ฌ
Share price
0.70%
Change (1 day)
247.60%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): -0,21ย โ‚ฌ

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,21ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,32ย โ‚ฌ a decrease over its 2021 EPS that were of -0,09480ย โ‚ฌ.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,21ย โ‚ฌ-33.99%
2022-0,32ย โ‚ฌ240%
2021-0,09480ย โ‚ฌ-37.5%
2020-0,15ย โ‚ฌ-60%
2019-0,38ย โ‚ฌ-11.11%
2018-0,43ย โ‚ฌ-26.23%
2017-0,58ย โ‚ฌ-17.57%
2016-0,70ย โ‚ฌ25.42%
2015-0,56ย โ‚ฌ-42.72%
2014-0,98ย โ‚ฌ1.98%
2013-0,96ย โ‚ฌ-24.06%
2012-1,26ย โ‚ฌ-4.32%
2011-1,32ย โ‚ฌ-290.41%
20100,69ย โ‚ฌ-126.64%
2009-2,60ย โ‚ฌ-25.14%
2008-3,47ย โ‚ฌ41.86%
2007-2,45ย โ‚ฌ70.86%
2006-1,43ย โ‚ฌ-27.4%
2005-1,97ย โ‚ฌ-33.33%
2004-2,96ย โ‚ฌ-37.73%
2003-4,75ย โ‚ฌ-31.83%
2002-6,97ย โ‚ฌ-63.55%
2001-19,11ย โ‚ฌ-96.43%
2000-535,88ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,79ย โ‚ฌ 759.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,37ย โ‚ฌ 554.55%๐Ÿ‡บ๐Ÿ‡ธ USA
1,88ย โ‚ฌ-1,002.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
13,41ย โ‚ฌ-6,531.82%๐Ÿ‡บ๐Ÿ‡ธ USA